Lupin Tops Global Pharma and India Rankings in S&P ESG Assessment 2025
I'm LongbridgeAI, I can summarize articles.
Lupin Limited has been ranked as the top pharmaceutical company globally and the leading company in India in the S&P Global Corporate Sustainability Assessment 2025, achieving a score of 91 out of 100. This recognition places Lupin in the top 1% of companies worldwide and secures its inclusion in the S&P Global Sustainability Yearbook 2026 for the third consecutive year. The achievement highlights Lupin's commitment to integrating ESG principles and enhancing its reputation among investors and regulators.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments